Selecting Specific Bio-markers and Researching Mechanisms of Immune Regulation From Inhalation Injury and Traumatic Lung Injury Based on Single Cell Sequencing Technology
1 other identifier
observational
21
1 country
1
Brief Summary
The goal of this observational study is to profile the circulating immunological traits of patients with traumatic lung injury (TLI) and inhalation injury (ILI),providing a new direction for the depth research of the pathogenesis, and providing new immune-related targets for diagnosis of the severity of lung injury and treatment. The investigators performed scRNA-seq of neutrophil and peripheral blood mononuclear cells (PBMCs) from 10 ml fresh circulating blood from 3 patients with TLI and 3 patients with ILI at longitudinal timepoints,as well as peripheral blood from 3 health controls(HCs).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedFirst Submitted
Initial submission to the registry
December 25, 2022
CompletedFirst Posted
Study publicly available on registry
February 8, 2023
CompletedFebruary 8, 2023
December 1, 2022
12 months
December 25, 2022
January 30, 2023
Conditions
Outcome Measures
Primary Outcomes (9)
Computerized tomography, CT
according to the proportion of rib fracture, pneumothorax, hemothorax,lung contusion in the image
1day
Computerized tomography, CT
according to the proportion of rib fracture, pneumothorax, hemothorax,lung contusion in the image
3 day
Computerized tomography, CT
according to the proportion of rib fracture, pneumothorax, hemothorax,lung contusion in the image
through study completion, an average of 2 weeks
Partial pressure of carbon dioxide in arterial blood, PaCO2
1day
Partial pressure of carbon dioxide in arterial blood, PaCO2
3 day
Partial pressure of carbon dioxide in arterial blood, PaCO2
through study completion, an average of 2 weeks
Oxygenation index and Fraction of Inspired Oxygen will be combined to report FiO2/PaO2
1 day
Oxygenation index and Fraction of Inspired Oxygen will be combined to report FiO2/PaO2
3 day
Oxygenation index and Fraction of Inspired Oxygen will be combined to report FiO2/PaO2
through study completion, an average of 2 weeks
Study Arms (3)
patients with traumatic lung injury (TLI)
patients with inhalation injury (ILI)
health controls(HCs)
Eligibility Criteria
3 patients with TLI and 3 patients with ILI age from 18 to 90 years old, admission within 24h after injury and diagnosed as traumatic lung injury by 2 surgeons on account of injury history and chest CT images. As well as peripheral blood from 3 health controls(HCs) who have no smoking history.
You may qualify if:
- Lung injury caused by burn trauma is confirmed, and the patient is hospitalized within 24 hours after burn or trauma (the clinician can make a definite diagnosis of lung injury based on the comprehensive judgment of the patient's etiology, history, clinical manifestations, blood gas analysis, laboratory tests and imaging);
- Patients with inhalation injury caused by head, face and neck burns or inhalation injury combined with multiple body burns \< 30%;
- Patients with simple inhalation injury;
- The normal control group should have no smoking history and be normal population;
- According to the provisions of Good Clinical Practice(GCP), the informed consent has been obtained and the informed consent has been signed to volunteer for the test.
You may not qualify if:
- Basic pulmonary diseases like chronic obstructive pulmonary disease (COPD), asthma and et al;
- Severe organ dysfunction;
- Autoimmune diseases;
- Tumor;
- Severe infection;
- Pregnant or nursing women;
- Fatal or life-threatening events caused by trauma;
- Any history which may interfere the results or increase the risk of patients judged by researchers.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Burn Surgery, the First Affiliated Hospital of Naval Medical University
Shanghai, Shanghai Municipality, 200433, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 25, 2022
First Posted
February 8, 2023
Study Start
January 1, 2021
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
February 8, 2023
Record last verified: 2022-12